Product Code: RP-ID-10012830 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10012830
Market Overview:
Global Biosimulation Market Size study, by Component (Software, Service), by Application (Drug Development, Drug Discovery, Others), by Industry (Government, IT & Telecommunication, Manufacturing, Others), and Regional Forecasts 2018-2025
Global Biosimulation Market to reach USD XXX billion by 2025.
Global Biosimulation Market valued approximately USD XXX billion in 2016 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2017-2025. Increasing need for the treatment with higher impact and low susceptibility to drug resistance and its requirement in Proteomic and Geomic technologies for development of advance therapeutics are the major factors driving the growth in the Global Biosimulation Market. However, the absence of proper standardization in the biosimulation methodology and lack of knowledge is likely to act as a major cause of concern. Biosimulation market is a tool for mathematical simulation of biological processes and systems. It provides model based calculation of biological system and processes and helps in drug discovery and development with the prediction of its failure and success. It helps in reduction of efforts and cost of drug development.
The regional analysis of Global Biosimulation Market is considered for the key regions such as North America, Europe, Asia and LAMEA and Rest of the World. North America is the leading/significant region across the world in terms of market share and possesses half of the total market share of the total market. Whereas Europe stands next for Global biosimulation market where Growth is Driven by government initiative.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Component:
 Software
 Service
o In-house Services
o Contract Services
By Application:
 Drug Development
 Drug Discovery
 Others
By Industry:
 Government
 IT & Telecommunication
 Manufacturing
 Others
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Simulation Plus, Inc., Dassault Systems SA, Schrodinger, Inc., Advanced Chemistry Development Inc, Physiomics PLC, Entelos, Inc., Rhenovia Pharma Ltd., Genedata AG, Leadscope, Inc., InhibOx Ltd. and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Biosimulation Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Simulation Plus, Inc.
Dassault Systems SA
Schrodinger, Inc
Advanced Chemistry Development, Inc
Physiomics PLC.
Entelos, Inc.
Rhenovia Pharma Ltd.
Genedata AG
Leadscope, Inc
InhibOx Ltd
Related Reports
Proof of Quality & Reliability
